Schlattmann, P., Lehmann, T., Rahmel, T., Roth, J., Kranke, P., Brunkhorst, F. M., . . . Schmidt, J. (2024). Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): Study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial. BMJ Publishing Group.
Chicago Style (17th ed.) CitationSchlattmann, Peter, et al. Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): Study Protocol for a Randomised, Placebo-controlled Phase IIa Dose-escalation Trial. BMJ Publishing Group, 2024.
MLA (9th ed.) CitationSchlattmann, Peter, et al. Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): Study Protocol for a Randomised, Placebo-controlled Phase IIa Dose-escalation Trial. BMJ Publishing Group, 2024.
Warning: These citations may not always be 100% accurate.